MAGELLAN TECHNOLOGY INC
NT 10-Q, 2000-08-15
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: FONIX CORP, NT 10-Q, 2000-08-15
Next: COMMON GOAL HEALTH CARE PENSION & INCOME FUND L P II, NT 10-Q, 2000-08-15




                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C.  20549

                               FORM 12b-25

                        NOTIFICATION OF LATE FILING

(Check one):  [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K
              [x] Form 10-Q [ ] Form N-SAR

              For Period Ended:  June 30, 2000
              [ ] Transition Report on Form 10-K
              [ ] Transition Report on Form 20-F
              [ ] Transition Report on Form 11-K
              [ ] Transition Report on Form 10-Q
              [ ] Transition Report on Form N-SAR
              For the Transition Period Ended:___________________________

Read Instructions (on back page) before preparing form.  Please
print or type.

Nothing in this Form Shall be construed to imply that the Commission has
verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:_______________________________.

Part I - Registrant Information

Full Name of Registrant

     MAGELLAN TECHNOLOGY, INC.

Former Name if Applicable

     N/A

Address of Principal Executive Office

12411 South 265 West, Suite F

City, State and Zip Code

Draper, Utah 84020

Part II - Rules 12b-25 (b) and (c)

If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25 (b), the
following should be completed.  (Check box if appropriate)

     (a)  The reasons described in reasonable detail in Part III of this form
          could not be eliminated without unreasonable effort or expense;
     (b)  The subject annual report or semi-annual report/portion thereof will
          be filed on or before the fifteenth calendar day following the
[X]       prescribed due date; or the subject quarterly report/portion thereof
          will be filed on or before the fifth calendar day following the
          prescribed due date; and
     (c)  The accountant's statement or other exhibit required by
          Rule 12b-25(c) has been attached if applicable.

Part III - Narrative

State below in reasonable detail the reasons why the Form 10-K, 11-K, 20-F,
10-Q or N-SAR or portion thereof, could not be filed within the prescribed
time period.

Company representatives were unable to assemble the materials necessary for
a complete filing in a timely manner.


<PAGE>

PART IV - Other Information

(1)  Name and telephone number of person to contact in regard to this
     notification

     Reed Steiner                   (801) 501-7517

(2)  Have all other periodic reports required under Section 13 or 15(d) of
     the Securities and Exchange Act of 1934 or Section 30 of the Investment
     Company Act of 1940 during the preceding 12 months (or for such shorter
     period that the registrant was required to file such reports) been filed?
     If answer is no, identify report(s).                 [X] Yes  [ ] No

(3)  Is it anticipated that any significant change in results of operations
     from the corresponding period for the last fiscal year will be reflected
     by the earnings statements to be included in the subject report or portion
     thereof?                                             [ ] Yes  [X] No

     If so attach an explanation of the anticipated change, both narratively
     and quantitatively, and, if appropriate, state the reasons why a
     reasonable estimate of the results can not be made.


_______________________________________________________________________________

                           MAGELLAN TECHNOLOGY, INC.
                    -----------------------------------------
                  (Name of Registrant as specified in Charter)

Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.


Date:  August 15, 2000     By:/s/ William A. Fresh
                             -----------------------------------
                             William A. Fresh
                             Chairman and Chief Executive Officer

INSTRUCTION;  The form may be signed by an executive officer of the registrant
or by any other duly authorized representative.  The name and title of the
person signing the form shall be typed or printed beneath the signature.  If
the state is signed on behalf of the registrant by an authorized
representative (other than an executive officer), evidence of the
representative's authority to sign on behalf of the registrant shall be filed
with the form.






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission